201 related articles for article (PubMed ID: 11280741)
1. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
[TBL] [Abstract][Full Text] [Related]
2. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
3. Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
Pretlow TP; Bird RP
Cancer Res; 2001 Oct; 61(20):7699-701. PubMed ID: 11606415
[No Abstract] [Full Text] [Related]
4. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
5. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
Furihata T; Kawamata H; Kubota K; Fujimori T
Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin expression is altered in human colonic aberrant crypt foci.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
10. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
11. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
12. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats.
Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Mori H; Yoshimi N
Cancer Lett; 2004 Mar; 205(2):133-41. PubMed ID: 15036645
[TBL] [Abstract][Full Text] [Related]
13. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats.
Tsukamoto T; Sakai H; Hirata A; Fukami H; Tatematsu M
Exp Toxicol Pathol; 2006 Mar; 57(4):283-9. PubMed ID: 16414254
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
[TBL] [Abstract][Full Text] [Related]
17. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
18. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
Hirose Y; Kuno T; Yamada Y; Sakata K; Katayama M; Yoshida K; Qiao Z; Hata K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):107-11. PubMed ID: 12538355
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous development of aberrant crypt foci in F344 rats.
Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
[TBL] [Abstract][Full Text] [Related]
20. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
Yamada Y; Mori H
Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
